Bio-Techne Corp.

TECH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2010 FY2009
Operating Activities
Net Income $109.8M $105.2M
Depreciation & Amortization $8.1M $7.8M
Depreciation
Amortization
Stock-Based Compensation
Net Cash from Operating Activities $111.3M $111.3M
Investing Activities
Capital Expenditures $4.6M $6.6M
Business Acquisitions $0 $0
Net Cash from Investing Activities $-114.6M $21.3M
Financing Activities
Dividends Paid $38.4M $28.2M
Stock Repurchases $15.0M $90.6M
Net Cash from Financing Activities $-50.5M $-119.4M
Net Change in Cash $-66.8M $-6.1M
Free Cash Flow $106.6M $104.8M
← Newer Page 3 of 3 Older →